
E.CA Economics announced that Alexis Walckiers will be joining its Brussels office as a Director on 1 September 1, 2020. E.CA’s leadership team is now composed of six Directors, working from E.CA’s main offices in Berlin and Brussels, leading a group of more than 40 antitrust economists.
Alexis Walckiers comes to E.CA as the former Chief Economist of the Belgian Competition Authority (BCA). There, together with the team he built up, Alexis advised both investigation teams and competition colleges on the use of economic tools in competition cases. Some of the recent, leading cases during his tenure were the merger between the supermarket chains Ahold and Delhaize and the takeover of De Vijver Media by Telenet (Liberty Global).
Walckiers holds a PhD in Economics from the ECARES Université libre de Bruxelles where he teaches economics at the Solvay business school. His recent papers on vertical restraints and hub-and-spoke collusion have been published in the International Journal of Industrial Organization and the Journal of European Competition Law and Practice.
Hans W. Friederiszick, one of the founding Directors of E.CA Economics, commented, “Alexis has a proven track record of offering robust economic advice in a law & economics setting. This matches E.CA’s strong reputation with European competition authorities.”
Full Content: E.CA
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas